JPRN-UMIN000049027已完成Unknown
A double-blind, randomized study of the efficacy of tapering programmed intermittent epidural bolus (t-PIEB) in video-assisted thoracic surgery (Pilot study) - Efficacy of t-PIEB in video-assisted thoracic surgery (Pilot study)
Department of Anesthesiology and Critical Care Hiroshima University0 个研究点目标入组 46 人开始时间: 2022年9月26日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe diabetes mellitus (HbA1c > 8.4). Patients whose procedure is changed to thoracotomy during surgery. Patients with the inadequate effect of epidural anesthesia at the end of general anesthesia. Patients considered unsuitable by anesthesiologists.
研究者
相似试验
进行中（未招募）
不适用
A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in children - Efficacy of cycloplegicsDepth of cycloplegiachanges of astigmatismrecuperation from cycloplegia and mydriasisMedDRA version: 12.1Level: LLTClassification code 10011719Term: CycloplegiaMedDRA version: 12.1Level: PTClassification code 10011719Term: CycloplegiaEUCTR2010-021410-34-NLMedical Centre Haaglanden423
已完成
3 期
A double blind randomized study on the efficacy of cyclopentolate 1% and cyclopentolate 1% with tropicamide 1% in childreNL-OMON34025Medisch Centrum Haaglanden419
已完成
不适用
Double-blind randomised study into the efficacy of codeine phosphate analgesia after cleft palate repair in infantsCleft palateISRCTN86816150Department of Health
已完成
不适用
A double-blind randomized trial of the efficacy of replacing sugary drinks by low sugar alternatives on body weight and fat mass in school schildren aged 5-10 yearsovergewicht/obesitasoverweightobesityNL-OMON33427Vrije Universiteit600
进行中（未招募）
1 期
Efficacy and Safety of REGN727 added-on to Rosuvastatin versus Ezetimibe added-on to Rosuvastatin versus Rosuvastatin dose increase in patients who are not controlled on RosuvastatiPatients with Non-familial hypercholesterolemia or heterozygous familial hypercholesterolemia (heFH) at high CV risk who are not adequately controlled with rosuvastatin (10mg or 20mg) with or without other lipid-modifying therapy (LMT) (excluding EZE)MedDRA version: 14.1Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-002333-11-ESRegeneron Pharmaceuticals, Inc.305